Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T-type Ca2+ channels and pharmacological blockade: potential pathophysiological relevance

S I Ertel1, E A Ertel, J P Clozel

  • 1Pharma Division, F. Hoffmann-La Roche Ltd., Basel, Switzerland.

Cardiovascular Drugs and Therapy
|March 26, 1998
PubMed
Summary

Low-voltage-activated T-type calcium (Ca2+) channels are found in many tissues and play roles in growth and cardiac function. The drug mibefradil selectively blocks these channels, offering potential therapeutic benefits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary arterial hypertension: a comparison between children and adults.

The European respiratory journal·2011
Same author

The pharmacology of bosentan.

Expert opinion on investigational drugs·2005
Same author

Combination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2002
Same author

Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure.

Acta pharmacologica Sinica·2001
Same author

Endothelin mediates the altered renal hemodynamics associated with experimental congestive heart failure.

Journal of cardiovascular pharmacology·2001
Same author

Piperidine renin inhibitors: from leads to drug candidates.

Farmaco (Societa chimica italiana : 1989)·2001

Area of Science:

  • Cardiovascular Physiology
  • Cellular Electrophysiology
  • Pharmacology

Background:

  • Low-voltage-activated T-type calcium (Ca2+) channels are ubiquitously expressed in excitable and non-excitable cells.
  • These channels exhibit distinct properties including low voltage activation, slow deactivation, and Ni2+ sensitivity.
  • Existing pharmacological blockers for T-type Ca2+ channels often lack specificity and potency.

Purpose of the Study:

  • To review the characteristics and physiological roles of T-type Ca2+ channels.
  • To discuss the complex modulation of T-type Ca2+ currents by various signaling molecules.
  • To highlight the potential of selective T-type Ca2+ channel blockers, exemplified by mibefradil.

Main Methods:

  • Literature review of T-type Ca2+ channel properties, distribution, and function.

Related Experiment Videos

  • Analysis of physiological modulators affecting T-type Ca2+ currents.
  • Evaluation of mibefradil's pharmacological profile and therapeutic implications.

    • Main Results:

    • T-type Ca2+ channels are implicated in diverse physiological processes, including cell growth, neuronal regulation, and cardiac function.
    • Complex hormonal and neurotransmitter systems modulate T-type Ca2+ channel activity.
    • Mibefradil demonstrates selective T-type Ca2+ channel blockade, leading to reduced vascular resistance and heart rate without adverse effects.

    Conclusions:

    • T-type Ca2+ channels are critical for numerous physiological and pathophysiological processes.
    • Selective blockade of T-type Ca2+ channels represents a promising therapeutic strategy.
    • Mibefradil's unique profile suggests its utility in treating conditions like hypertension and angina.